مرکز تحقیقات غدد و متابولیسم | The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes a randomized double-blind clinical trial

مرکز تحقیقات غدد و متابولیسم | The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes a randomized double-blind clinical trial
سایت دانشگاه | 04 آبان 1404
logo

مرکز تحقیقات غدد و متابولیسم

دانشگاه علوم پزشکی تهران

  • تاریخ انتشار : 1404/06/13 - 11:30
  • : 19
  • زمان مطالعه : کمتر از یک دقیقه

The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes a randomized double-blind clinical trial

 {faces}

Diabetic neuropathy is the most prevalent complication of diabetes mellitus, affecting up to 50% of patients with type 2 diabetes mellitus (T2DM). Among the various types of diabetic neuropathy, diabetic peripheral neuropathy (DPN) is the most common. Numerous animal studies have highlighted a strong association between the improvement of DPN and curcumin supplementation, particularly due to curcumin’s anti-inflammatory and antioxidant properties. However, the effects of curcumin on DPN have been evaluated in only one randomized controlled trial. In our study, we assessed the efficacy and safety of a 16-week supplementation with nanocurcumin in T2DM patients suffering from DPN.

  • Article_DOI : org/10.1186/s12937-025-01184-8
  • نویسندگان : asieh mansour, hadis gerami, sayed mahmoud sajjadi-jazi, mohammad reza mohajeri-tehrani , hamid reza rahimi, atie sadat khorasanian, amir hossein esmaeili,atefeh amrollahi bioky, hamid reza fateh
  • گروه خبر : مقالات علمی,انگلیسی ,مقالات
  • کد خبر : 304106
کلمات کلیدی
فاطمه  ذاکرحسینی
تهیه کننده:

فاطمه ذاکرحسینی

0 نظر برای این مطلب وجود دارد

ارسال نظر

نظر خود را وارد نمایید:

متن درون تصویر را در جعبه متن زیر وارد نمائید *
متن مورد نظر خود را جستجو کنید
تنظیمات پس زمینه